- Expressions and Clinical Significances of c-met, c-erbB-2, COX-2, and IL-6 in the Biliary Tract Cancers
-
Joo HH, Song EY, Jin SH, Oh SH, Choi YK
- KMID: 937932
- Korean J Gastroenterol.
- 2007 Dec;50(6):370-378.
BACKGROUND/AIMS: c-met, c-erbB-2, interleukin (IL)-6, and cyclooxygenase (COX)-2 expressions are considered to be implicated in the carcinogenesis and progression of cholangiocarcinoma, but the molecular pathogenesis of cholangiocarcinoma is still... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of ErbB Receptor Proteins and TGF-alpha during Diethylnitrosamine-induced Hepatocarcinogenesis in the Rat Liver
-
Lee TY, Kim KT, Han SY
- KMID: 760707
- Korean J Hepatol.
- 2007 Mar;13(1):70-80.
BACKGROUND/AIMS: ErbB receptor proteins are transmembrane tyrosine kinase receptors; when they are activated by interaction with ligands, they generate diverse cellular responses, especially during lesion development and progression to... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder
-
Lim SD, Cho YM, Choi GS, Park HK, Paick SH, Kim WY, Kim SN, Yoon G
- KMID: 2164501
- J Korean Med Sci.
- 2015 Aug;30(8):1068-1077.
- doi: 10.3346/jkms.2015.30.8.1068
The study aimed to verify the prognostic utility, therapeutic application and clinical benefits of tumor substaging and HER2 status in papillary non-muscle invasive bladder cancer (NMIBC). Select NMIBC transurethral resection... -
- CITED
-
- Close
- SHARE
-
- Close
- Human Epidermal Growth Factor Receptor 2 Expression in Unresectable Gastric Cancers: Relationship with CT Characteristics
-
Lee JS, Kim SH, Im SA, Kim MA, Han JK
- KMID: 2427217
- Korean J Radiol.
- 2017 Oct;18(5):809-820.
- doi: 10.3348/kjr.2017.18.5.809
OBJECTIVE: To retrospectively analyze the qualitative CT features that correlate with human epidermal growth factor receptor 2 (HER2)-expression in pathologically-proven gastric cancers. MATERIALS AND METHODS: A total of 181 patients with... -
- CITED
-
- Close
- SHARE
-
- Close
